IP Verse

Individualized Vaccines For Cancer - EP2714071

The patent EP2714071 was granted to Biontech on Jul 10, 2019. The application was originally filed on May 23, 2012 under application number EP12723117A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2714071

BIONTECH
Application Number
EP12723117A
Filing Date
May 23, 2012
Status
Opposition Rejected
Jun 20, 2024
Grant Date
Jul 10, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANApr 14, 2020GRAF VON STOSCHADMISSIBLE
WITHERS & ROGERSApr 14, 2020GRAF VON STOSCHADMISSIBLE
IPRIME RENTSCH KAELINApr 9, 2020IPRIME RENTSCH KAELINWITHDRAWN

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2006EP09448-
DESCRIPTIONWO9633739
DESCRIPTIONWO9724447
EXAMINATIONEP1392341
EXAMINATIONEP2100620
EXAMINATIONUS2006188490
EXAMINATIONUS2006204523
EXAMINATIONWO03059381
EXAMINATIONWO2011143656
INTERNATIONAL-SEARCH-REPORTWO9740156
INTERNATIONAL-SEARCH-REPORTWO9934015
OPPOSITIONEP2100620
OPPOSITIONEP2569633
OPPOSITIONEP3473267
OPPOSITIONUS2006188490
OPPOSITIONUS2006204523
OPPOSITIONUS2008171711
OPPOSITIONUS8217016
OPPOSITIONWO0119408
OPPOSITIONWO02098443
OPPOSITIONWO03051401
OPPOSITIONWO03059381
OPPOSITIONWO2010037539
OPPOSITIONWO2011143656
OPPOSITIONWO9934015

Non-Patent Literature (NPL) Citations (155) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ABASTADO ET AL., J. IMMUNOL., (1993), vol. 151, no. 7, pages 3569 - 75-
DESCRIPTION- ABASTADO JP ET AL., J IMMUNOL., (19931001), vol. 151, no. 7, pages 3569 - 75-
DESCRIPTION- ADZHUBEI IA ET AL., NAT METHODS, (2010), vol. 7, pages 248 - 9-
DESCRIPTION- AJAY, S.S. ET AL., GENOME RES., (2011), vol. 21, pages 1498 - 1505-
DESCRIPTION- ALLARD ET AL., CLIN CANCER RES, (2004), vol. 10, pages 6897 - 6904-
DESCRIPTION- ALLARD WJ. ET AL., CLINICAL CANCER RESEARCH, (2004), vol. 10, pages 6897 - 6904-
DESCRIPTION- AZUMA ET AL., NATURE, (1993), vol. 366, pages 76 - 79-
DESCRIPTION- BAINBRIDGE, M.N. ET AL., GENOME BIOL., (2010), vol. 11, page R62-
DESCRIPTION- BANSAL, V., BIOINFORMATICS, (2010), vol. 26, pages 318 - 324-
DESCRIPTION- BERGER MF. ET AL., "Integrative analysis of the melanoma transcriptome", GENOME RES., (20100223), vol. 20, no. 4, pages 413 - 27-
DESCRIPTION- BIJKER MS ET AL., J IMMUNOL, (2007), vol. 179, pages 5033 - 40-
DESCRIPTION- BLOOM MB ET AL., EXP MED, (1997), vol. 185, pages 453 - 9-
DESCRIPTION- BREIMAN, L., STATIST. SCI., (2001), vol. 16, pages 199 - 231-
DESCRIPTION- CAMPBELL ET AL., NATURE, (2010), vol. 467, no. 7319, pages 1109 - 1113-
DESCRIPTION- CHOI ET AL., PROC. NATL. ACAD. SCI USA, (2009), vol. 106, pages 19096 - 19101-
DESCRIPTION- DALERBA P. ET AL., NATURE BIOTECHNOLOGY, (2011), vol. 29, pages 1120 - 1127-
DESCRIPTION- DATTA SK ET AL., J IMMUNOL, (2003), vol. 170, pages 4102 - 10-
DESCRIPTION- DEPRISTO, M.A. ET AL., NATURE GENETICS, (2011), vol. 43, pages 491 - 498-
DESCRIPTION- DEPRISTO, M.A., NATURE GENETICS, (2011), vol. 43, pages 491 - 498-
DESCRIPTION- DEY N ET AL., CANCER RES, (2008), vol. 68, pages 1862 - 71-
DESCRIPTION- DING L ET AL., HUM MOL GENET, (2010), vol. 19, pages R188 - R196-
DESCRIPTION- DRULEY, T.E. ET AL., NATURE METHODS, (2009), vol. 6, pages 263 - 265-
DESCRIPTION- ECHCHAKIR H ET AL., CANCER RES, (2001), vol. 61, pages 4078 - 83-
DESCRIPTION- EWEN, K.R. ET AL., AM. J. HUM. GENET., (2000), vol. 67, pages 727 - 736-
DESCRIPTION- FAWCETT, T., PATTERN RECOGN. LETT., (2006), vol. 27, pages 861 - 874-
DESCRIPTION- FRUMKIN D. ET AL., CANCER RESEARCH, (2008), vol. 68, page 5924-
DESCRIPTION- FUJITA, P.A. ET AL., NUCLEIC ACIDS RES., (2011), vol. 39, pages 876 - 882-
DESCRIPTION- "Generation and use of high quality cDNA from small amounts of total RNA by SMART PCR", CHENCHIK, A., Y ET AL., Gene Cloning and Analysis, BIOTECHNIQUES BOOKS, (1998), pages 305 - 319-
DESCRIPTION- GNIRKE, A. ET AL., NAT. BIOTECHNOL., (2009), vol. 27, pages 182 - 189-
DESCRIPTION- GNIRKE A ET AL., NAT BIOTECHNOL, (2009), vol. 27, pages 182 - 9-
DESCRIPTION- GNIRKE A ET AL., "Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing", NAT BIOTECHNOL, (2009), vol. 27, pages 182 - 189-
DESCRIPTION- HAJRA KM ET AL., APOPTOSIS, (2004), vol. 9, pages 691 - 704-
DESCRIPTION- HANSEN, K.D. ET AL., NUCLEIC. ACIDS. RES., (2010), vol. 38, page EL31-
DESCRIPTION- HODGES ET AL., NAT. GENET., (2007), vol. 39, pages 1522 - 1527-
DESCRIPTION- HOLTKAMP ET AL., BLOOD, (2006), vol. 108, pages 4009 - 17-
DESCRIPTION- HOLTKAMP S ET AL., BLOOD, (2006), vol. 108, pages 4009 - 17-
DESCRIPTION- HOLTKAMP, S. ET AL., BLOOD, (2006), vol. 108, pages 4009 - 4017-
DESCRIPTION- HOYT ET AL., EMBO J., (2006), vol. 25, no. 8, pages 1720 - 9-
DESCRIPTION- HOYT MA ET AL., EMBO J, (2006), vol. 25, no. 8, pages 1720 - 9-
DESCRIPTION- KIRCHER, M. ET AL., GENOME BIOL., (20090814), vol. 10, page R83-
DESCRIPTION- KREITER ET AL., CANCER IMMUNOL IMMUNOTHER, (2007), vol. 56, pages 1577 - 87-
DESCRIPTION- KREITER; KONRAD; SESTER ET AL., CANCER IMMUNOL. IMMUNOTHER., (2007), vol. 56, pages 1577 - 1587-
DESCRIPTION- KREITER, S. ET AL., CANCER IMMUNOL. IMMUNOTHER., (2007), vol. 56, pages 1577 - 1587-
DESCRIPTION- KREITER S ET AL., CANCER IMMUNOL IMMUNOTHER, (2007), vol. 56, pages 1577 - 87-
DESCRIPTION- KREITER S ET AL., CANCER RES, (2010), vol. 70, pages 9031 - 40-
DESCRIPTION- KREITER, S. ET AL., CANCER RESEARCH, (2010), vol. 70, no. 22, pages 9031 - 9040-
DESCRIPTION- KREITER S. ET AL., J. IMMUNOL., (2008), vol. 180, pages 309 - 318-
DESCRIPTION- KREITER, S. ET AL., J. IMMUNOL., (2008), vol. 180, pages 309 - 318-
DESCRIPTION- KREITER, S. ET AL., J.IMMUNOL., (2008), vol. 180, pages 309 - 318-
DESCRIPTION- KRIEG ET AL., NATURE, (1995), vol. 374, pages 546 - 549-
DESCRIPTION- KUHN, A. N. ET AL., GENE THER., (2010), vol. 17, pages 961 - 971-
DESCRIPTION- KUMAR P ET AL., NAT PROTOC, (2009), vol. 4, pages 1073 - 81-
DESCRIPTION- LANGMEAD B ET AL., GENOME BIOL, (2009), vol. 10, page R25-
DESCRIPTION- LANGMEAD, B. ET AL., GENOME BIOL., (2009), vol. 10, page R25-
DESCRIPTION- LANGMEAD B. ET AL., "Ultrafast and memory-efficient alignment of short DNA sequences to the human genome", GENOME BIOL, vol. IO, page R25-
DESCRIPTION- LASSMANN, T. ET AL., BIOINFORMATICS, (2011), vol. 27, pages 130 - 131-
DESCRIPTION- LEE YM ET AL., GENE, (2010), vol. 466, pages 16 - 25-
DESCRIPTION- LIAW, A.; WIENER, M., R NEWS, (2002), vol. 2, pages 18 - 22-
DESCRIPTION- LI, H., BIOINFORMATICS, (2011), vol. 27, pages 1157 - 1158-
DESCRIPTION- LI H, BIOINFORMATICS, (2011), vol. 27, pages 1157 - 8-
DESCRIPTION- LI, H.; DURBIN, R., BIOINFORMATICS, (2009), vol. 25, pages 1754 - 1760-
DESCRIPTION- LI, H; DURBIN, R., BIOINFORMATICS, (2009), vol. 25, pages 1754 - 1760-
DESCRIPTION- LI H; DURBIN R, BIOINFORMATICS, (2009), vol. 25, pages 1754 - 60-
DESCRIPTION- LI H.; DURBIN R., "Fast and accurate short read alignment with Burrows-Wheeler Transform", BIOINFORMATICS, (2009), vol. 25, pages 1754 - 60-
DESCRIPTION- LI, H. ET AL., BIOINFORMATICS, (2009), vol. 25, pages 2078 - 2079-
DESCRIPTION- LI H., "Improving SNP discovery by base alignment quality", BIOINFORMATICS, (20110213), vol. 27, no. 8, pages 1157 - 8-
DESCRIPTION- LUTZ MB ET AL., J IMMUNOL METHODS, (1999), vol. 223, pages 77 - 92-
DESCRIPTION- MAHVI ET AL., IMMUNOLOGY AND CELL BIOLOGY, (1997), vol. 75, pages 456 - 460-
DESCRIPTION- MALOY ET AL., PROC NATL ACAD SCI USA, (2001), vol. 98, pages 3299 - 303-
DESCRIPTION- MCKENNA A ET AL., GENOME RES, (2010), vol. 20, pages 1297 - 303-
DESCRIPTION- MCKENNA A. ET AL., "The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data", GENOME RES., (20100719), vol. 20, no. 9, pages 1297 - 303-
DESCRIPTION- MELIEF CJ; VAN DER BURG SH, NAT REV CANCER, (2008), vol. 8, pages 351 - 60-
DESCRIPTION- MORTAZAVI A. ET AL., "Mapping and quantifying mammalian transcriptomes by RNA-Seq", NAT METHODS, (20080530), vol. S, no. 7, pages 621 - 8-
DESCRIPTION- MORTAZAVI, A. ET AL., "Mapping and quantifying mammalian transcriptomes by rna-seq", NAT METHODS, (2008), vol. 5, no. 7, pages 621 - 628-
DESCRIPTION- MORTAZAVI, A. ET AL., NAT. METHODS, (2008), vol. 5, pages 621 - 628-
DESCRIPTION- MORTAZAVI A ET AL., NAT METHODS, (2008), vol. 5, pages 621 - 8-
DESCRIPTION- "Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome", NATURE, (2002), vol. 420, pages 520 - 562-
DESCRIPTION- "Mouse Genome Sequencing Consortium", NATURE, (2002), vol. 420, pages 520 - 562-
DESCRIPTION- NAGRATH ET AL., NATURE, (2007), vol. 450, pages 1235 - 1239-
DESCRIPTION- NG, PC ET AL., PLOS GEN., (2008), vol. 4, no. 8, pages 1 - 15-
DESCRIPTION- PANTEL ET AL., TRENDS MOL MED, (2010), vol. 16, no. 9, pages 398 - 406-
DESCRIPTION- PFEIFER GP ET AL., MUTAT RES, (2005), vol. 571, pages 19 - 31-
DESCRIPTION- POKROVSKAYA; GUREVICH, ANAL. BIOCHEM., (1994), vol. 220, pages 420 - 423-
DESCRIPTION- PRUITT KD. ET AL., "NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins", NUCLEIC ACIDS RES., (20050101), vol. 33, pages D501 - 4-
DESCRIPTION- PRUITT, K.D. ET AL., NUCLEIC ACIDS RES., (2005), vol. 33, pages 501 - 504-
DESCRIPTION- PRUITT KD ET AL., NUCLEIC ACIDS RES, (2007), vol. 35, pages D61 - D65-
DESCRIPTION- RAO CG. ET AL., INTERNATIONAL JOURNAL OF ONCOLOGY, (2005), vol. 27, page 49-
DESCRIPTION- RONAGHI ET AL., "A sequencing method based on real-time pyrophosphate", SCIENCE, (1998), vol. 281, no. 5375, pages 363 - 365-
DESCRIPTION- SATHIRAPONGSASUTI JF ET AL., BIOINFORMATICS, (2011), vol. 27, pages 2648 - 54-
DESCRIPTION- SCHLESSINGER A; ROST B., PROTEINS, (20051001), vol. 61, no. 1, pages 115 - 26-
DESCRIPTION- SCHLESSINGER ET AL., PROTEINS, (2005), vol. 61, no. 1, pages 115 - 26-
DESCRIPTION- SCHREURS MW ET AL., CANCER RES, (2000), vol. 60, pages 6995 - 7001-
DESCRIPTION- SCHULZ O ET AL., NATURE, (2005), vol. 433, pages 887 - 92-
DESCRIPTION- SCIENCE, (1995), vol. 268, pages 1432 - 1434-
DESCRIPTION- SHERRY, S.T. ET AL., NUCLEIC ACIDS RES., (2009), vol. 29, pages 308 - 311-
DESCRIPTION- SO ET AL., MOL. CELLS, (1997), vol. 7, pages 178 - 186-
DESCRIPTION- SU MW ET AL., J IMMUNOL, (1993), vol. 151, pages 658 - 67-
DESCRIPTION- SUZUKI ET AL., MOL. ONCOL., (2007), vol. 1, no. 2, pages 172 - 180-
DESCRIPTION- TAUB, M.A. ET AL., GENOME MED., (2010), vol. 2, page 87-
DESCRIPTION- TEER; MULLIKIN, HUMAN MOL GENET, (2010), vol. 19, no. 2, pages R145 - 51-
DESCRIPTION- TOES RE ET AL., J IMMUNOL, (1996), vol. 156, pages 3911 - 8-
DESCRIPTION- VAN TASSELL, C.P. ET AL., NATURE METHODS, (2008), vol. 5, pages 247 - 252-
DESCRIPTION- VERHAAK RG ET AL., CANCER CELL, (2010), vol. 17, pages 98 - 110-
DESCRIPTION- VOELKERDING ET AL., "Next generation sequencing: From basic research to diagnostics", CLINICAL CHEMISTRY, (2009), vol. 55, pages 641 - 658-
DESCRIPTION- WATERSTON RH ET AL., NATURE, (2002), vol. 420, pages 520 - 62-
DESCRIPTION- WEIDE ET AL., J. IMMUNOTHER., (2008), vol. 31, pages 180 - 188-
DESCRIPTION- WEI X ET AL., NAT GENET, (2011), vol. 43, pages 442 - 6-
DESCRIPTION- ZHANG ET AL., J. BIOL. CHEM., (2004), vol. 279, no. 10, pages 8635 - 41-
DESCRIPTION- ZHANG ET AL., "The impact of next-generation sequencing on genomics", J. GENET GENOMICS, (2011), vol. 38, no. 3, pages 95 - 109-
DESCRIPTION- ZHANG M.; COFFINO P., J BIOL CHEM, (2004), vol. 279, no. 10, pages 8635 - 41-
DESCRIPTION- ZHANG, Z.; GERSTEIN, M., NUCLEIC ACIDS RES, (2003), vol. 31, pages 5338 - 5348-
DESCRIPTION- ZILFOU JT ET AL., COLD SPRING HARB PERSPECT BIOL, (2009), vol. 1, page A001883-
DESCRIPTION- ZWAVELING S ET AL., CANCER RES, (2002), vol. 62, pages 6187 - 93-
EXAMINATION- NIELSEN J S ET AL, "An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 360, no. 1-2, ISSN 0022-1759, (20100831), pages 149 - 156, (20100715), XP027222180-
EXAMINATION- SMITH S G ET AL, "Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20011201), vol. 7, no. 12, ISSN 1078-0432, pages 4253 - 4261, XP002219398-
EXAMINATION- LUISA NOVELLINO ET AL, "A listing of human tumor antigens recognized by T cells: March 2004 update", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, (20050301), vol. 54, no. 3, doi:10.1007/S00262-004-0560-6, ISSN 1432-0851, pages 187 - 207, XP019333092
EXAMINATION- H-G Rammensee ET AL, "Cancer Vaccines: Some Basic Considerations", Genomic and Personalized Medicine, Elsevier, (20081111), page 573589, XP055348899
EXAMINATION- RAMMENSEE H-G ET AL, "TOWARDS PATIENT-SPECIFIC TUMOR ANTIGEN SELECTION FOR VACCINATION", IMMUNOLOGICAL REVI, WILEY-BLACKWELL PUBLISHING, INC, US, (20021001), vol. 188, doi:10.1034/J.1600-065X.2002.18815.X, ISSN 0105-2896, pages 164 - 176, XP008026240
EXAMINATION- PILLA L ET AL, "Multipeptide vaccination in cancer patients", EXPERT OPINION ON BIOLOGICAL THERAPY, INFORMA HEALTHCARE, ASHLEY, LONDON; GB, (20090801), vol. 9, no. 8, doi:10.1517/14712590903085109, ISSN 1471-2598, pages 1043 - 1055, XP008176908
INTERNATIONAL-SEARCH-REPORT- GJERTSEN ET AL, "Mutated ras peptides as vaccines in immunotherapy of cancer", VOX SANGUINIS, S. KARGER AG, BASEL, CH, (19980101), vol. 74, no. 2, ISSN 0042-9007, pages 489 - 495, XP002127145 [X] 18,22 * abstract * * table 1 * [Y] 1-17,19-21-
INTERNATIONAL-SEARCH-REPORT- MATEO L ET AL, "An HLA-A2 polyepitope vaccine for melanoma immunotherapy", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19991001), vol. 163, no. 7, ISSN 0022-1767, pages 4058 - 4063, XP002244411 [A] 10,11,14,15 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- RAHMA OSAMA E ET AL, "A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma", JOURNAL OF TRANSLATIONAL MEDICINE, BIOMED CENTRAL, LONDON, GB, (20100128), vol. 8, no. 1, ISSN 1479-5876, page 8, XP021068353 [X] 18,22 * abstract * * page 2, column r, paragraph 1 - page 3, column l, paragraph 2 * * tables 1,2 * [Y] 1-17,19-21-
INTERNATIONAL-SEARCH-REPORT- SEBASTIAN KREITER ET AL, "Tumor vaccination using messenger RNA: prospects of a future therapy", CURRENT OPINION IN IMMUNOLOGY, (20110413), vol. 23, no. 3, doi:10.1016/j.coi.2011.03.007, ISSN 0952-7915, pages 399 - 406, XP055018902 [A] 16 * the whole document *
INTERNATIONAL-SEARCH-REPORT- PANTEL K ET AL, "Circulating tumour cells in cancer patients: challenges and perspectives", TRENDS IN MOLECULAR MEDICINE, ELSEVIER CURRENT TRENDS, GB, vol. 16, no. 9, doi:10.1016/J.MOLMED.2010.07.001, ISSN 1471-4914, (20100901), pages 398 - 406, (20100729), XP027433109 [AD] 3,4 * the whole document *
INTERNATIONAL-SEARCH-REPORT- FAWCETT ET AL, "An introduction to ROC analysis", PATTERN RECOGNITION LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 27, no. 8, doi:10.1016/J.PATREC.2005.10.010, ISSN 0167-8655, (20060601), pages 861 - 874, (20060601), XP025053099 [ID] 45 * the whole document *
INTERNATIONAL-SEARCH-REPORT- KESSLER J H ET AL, "Identification of T-cell epitopes for cancer immunotherapy", LEUKEMIA, MACMILLAN PRESS LTD, US, vol. 21, no. 9, doi:10.1038/SJ.LEU.2404787, ISSN 0887-6924, (20070901), pages 1859 - 1874, (20070705), XP002516100 [A] 1-22 * page 1860, column l, paragraph 4 - page 1861, column r, paragraph 2 *
INTERNATIONAL-SEARCH-REPORT- JOHN D. STOREY, "A direct approach to false discovery rates", PLOS COMPUTATIONAL BIOLOGY, (20020801), vol. 64, no. 3, doi:10.1111/1467-9868.00346, ISSN 1369-7412, pages 479 - 498, XP055061495 [I] 23-44 * the whole document *
INTERNATIONAL-SEARCH-REPORT- TOBIAS SJÖBLOM ET AL, "The Consensus Coding Sequences of Human Breast and Colorectal Cancers", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, (20061013), vol. 314, doi:10.1126/SCIENCE.1133427, ISSN 0036-8075, pages 268 - 274, XP007901261 [A] 1-22 * abstract * * page 268, column r, paragraph 3 - page 269, column r, paragraph 1 * * page 274, column l, paragraph 1 *
INTERNATIONAL-SEARCH-REPORT- N. H. SEGAL ET AL, "Epitope Landscape in Breast and Colorectal Cancer", CANCER RESEARCH, (20080201), vol. 68, no. 3, doi:10.1158/0008-5472.CAN-07-3095, ISSN 0008-5472, pages 889 - 892, XP055044926 [A] 1-22 * abstract * * page 889, column r, paragraph 3 *
INTERNATIONAL-SEARCH-REPORT- J. C. CASTLE ET AL, "Exploiting the mutanome for tumor vaccination", CANCER RESEARCH, (20120101), doi:10.1158/0008-5472.CAN-11-3722, ISSN 0008-5472, XP055018897 [XP] 1-22 * the whole document *
INTERNATIONAL-SEARCH-REPORT- GIORGIO PARMIANI ET AL, "Unique human tumor antigens: immunobiology and use in clinical trials.", THE JOURNAL OF IMMUNOLOGY, (20070201), vol. 178, no. 4, ISSN 0022-1767, pages 1975 - 1979, XP055044894 [Y] 1-17,19-21 * page 1977, column l, paragraph 2 *
OPPOSITION- 19000101, "Epitope", WIKIPEDIA, pages 1 - 2, WIKIPEDIA, URL: http://en.wikipedia.org/w/index.php?title=Epitope&printable=yes, XP003026671-
OPPOSITION- KREITER SEBASTIAN, ET AL, "Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.", The Journal of Immunology, American Association of Immunologists, US, US, (20080101), vol. 180, no. 1, ISSN 0022-1767, pages 309 - 318, XP002527745-
OPPOSITION- Nielsen, J.S. ; Wick, D.A. ; Tran, E. ; Nelson, B.H. ; Webb, J.R., "An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies", JOURNAL OF IMMUNOLOGICAL METHODS., ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM., NL, NL, (20100831), vol. 360, no. 1-2, ISSN 0022-1759, pages 149 - 156, XP027222180-
OPPOSITION- PASCOLO STEVE, "Messenger RNA-based vaccines.", Expert opinion on biological therapy, Informa Healthcare, UK, UK, (20040801), vol. 4, no. 8, ISSN 1744-7682, pages 1285 - 1294, XP002764729-
OPPOSITION- Thorsten H Ecke, Et Al, "TP53 Gene Mutations in Prostate Cancer Progression", ANTICANCER RESEARCH, (20100101), vol. 30, pages 1579 - 1586, XP055744445-
OPPOSITION- Harpreet Singh-Jasuja, Niels P. N. Emmerich, Hans-Georg Rammensee, "The T�bingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy", Cancer Immunology, Immunotherapy, Springer-Verlag, (20040301), vol. 53, no. 3, doi:10.1007/s00262-003-0480-x, ISSN 03407004, pages 187 - 195, XP055015114
OPPOSITION- Hans-Georg Rammensee, "Cancer Vaccines: Some basic Consideration", Genomic and Personalized Medicine 2nd Edition, (20090101), pages 573 - 589, XP055744440
OPPOSITION- RAMMENSEE H-G, ET AL., "TOWARDS PATIENT-SPECIFIC TUMOR ANTIGEN SELECTION FOR VACCINATION", Immunological Reviews, Wiley-Blackwell Publishing, Inc., US, US, (20021001), vol. 188, doi:10.1034/j.1600-065X.2002.18815.x, ISSN 0105-2896, pages 164 - 176, XP008026240
OPPOSITION- SUHRBIER A, "MULTI-EPITOPE DNA VACCINES", IMMUNOLOGY AND CELL BIOLOGY, CARLTON, AU, AU, (19970801), vol. 75, no. 04, doi:10.1038/icb.1997.63, ISSN 0818-9641, pages 402 - 408, XP001068789
OPPOSITION- Cornelis J.M. Melief, Sjoerd H. Van Der Burg, "Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines", Nature Reviews Cancer, Nature Pub. Group, (20080501), vol. 8, no. 5, doi:10.1038/nrc2373, ISSN 1474175X, pages 351 - 360, XP055019108
OPPOSITION- KESSLER J H, MELIEF C J M, "Identification of T-cell epitopes for cancer immunotherapy", Blood Cancer Journal, Nature Publishing Group UK, London, London, (20070901), vol. 21, no. 9, doi:10.1038/sj.leu.2404787, ISSN 0887-6924, pages 1859 - 1874, XP002516100
OPPOSITION- L. Ding, M. C. Wendl, D. C. Koboldt, E. R. Mardis, "Analysis of next-generation genomic data in cancer: accomplishments and challenges", Human Molecular Genetics, (20101015), vol. 19, no. R2, doi:10.1093/hmg/ddq391, ISSN 09646906, pages R188 - R196, XP055113696
OPPOSITION- Rammensee H-G, "Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer", IMMUNOLOGY AND CELL BIOLOGY, CARLTON, AU, AU, (20060101), vol. 84, no. 3, doi:10.1111/j.1440-1711.2006.01442.x, ISSN 0818-9641, pages 290 - 294, XP009092600
OPPOSITION- Ugur Sahin, Özlem Türeci, "Personalized vaccines for cancer immunotherapy", Science, American Association for the Advancement of Science, US, US, (20180323), vol. 359, no. 6382, doi:10.1126/science.aar7112, ISSN 0036-8075, pages 1355 - 1360, XP055744435
OPPOSITION- CASTLE JOHN C ET AL, "Exploiting the Mutanome for Tumor Vaccination", CANCER RESEARCH, (20120301), vol. 72, no. 5, doi:10.1158/0008-5472.CAN-11-3722, pages 1081 - 1091, XP002695346
OPPOSITION- CARRALOT et al., "Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas", Genetic Vaccines and Therapy, (20050000), vol. 3, page 6, XP021009760
OPPOSITION- Suhrbier A, "Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes.", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, GB, (20020801), vol. 1, no. 2, doi:10.1586/14760584.1.2.207, ISSN 1476-0584, pages 207 - 213, XP008094488
OPPOSITION- Lijin Li, Peter Goedegebuure , Elaine R. Mardis , Matthew J.C. Ellis , Xiuli Zhang , John M. Herndon, Timothy P. Fleming , Beatriz M. Carreno , Ted H. Hansen and William E. Gillanders, "Cancer genome sequencing and its implications for personalized cancer vaccines.", Cancers, M D P I AG, CH, CH, (20111125), vol. 3, no. 4, doi:10.3390/cancers3044191, ISSN 2072-6694, pages 4191 - 4211, XP002730781
OTHER- Rammensee et al., "TOWARDS PATIENT-SPECIFIC TUMOR ANTIGEN SELECTION FOR VACCINATION", IMMUNOLOGICAL REVIEWS, vol. 188, (20020000), pages 164 - 176, XP008026240
OTHER- Fotin-Mleczek et al., "Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity", JOURNAL OF IMMUNOTHERAPY, vol. 34, no. 1, (20110100), pages 1 - 15, XP008144564
OTHER- Qin et al, "Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens", Immunology, vol. 117, (20060000), pages 419 - 430, XP002471889
OTHER- Kreiter et al., "Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity", CANCER RESEARCH, vol. 70, no. 22, (20101115), pages 9031 - 9040, XP055344954
OTHER- Sensi et al., "Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell-Mediated Patient-Specific Immunotherapy", Clinical Cancer Research, vol. 12, no. 17, (20060901), pages 5023 - 5032, XP055094295
OTHER- Brennick et al., "Neoepitopes as cancer immunotherapy targets: key challenges and opportunities", Immunotherapy, vol. 9, no. 4, (20170000), pages 361 - 371, XP055471535

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents